KBPH — Kyto Technology and Life Science Balance Sheet
0.000.00%
FinancialsHighly SpeculativeMicro Cap
Annual balance sheet for Kyto Technology and Life Science, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2017 March 31st | 2018 March 31st | 2019 March 31st | 2020 March 31st | 2021 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0 | 0 | 0.094 | 0.034 | 1.44 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | — | — | 0.001 | 0.001 | 0 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0 | 0.007 | 0.095 | 0.034 | 1.61 |
| Long Term Investments | |||||
| Total Assets | 0 | 0.007 | 1.59 | 2.7 | 8.43 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.226 | 0.324 | 0.029 | 0.032 | 1.44 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.226 | 0.324 | 0.029 | 0.032 | 1.44 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | -0.226 | -0.317 | 1.56 | 2.67 | 6.99 |
| Total Liabilities & Shareholders' Equity | 0 | 0.007 | 1.59 | 2.7 | 8.43 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |